Yi Chen Analyst PerformanceManaging Director of Equity Research at HC WainwrightYi Chen is a stock analyst at HC Wainwright focused in the healthcare sector, covering 73 publicly traded companies. Over the past year, Yi Chen has issued 133 stock ratings, including buy and hold recommendations. While full access to Yi Chen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yi Chen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings506 Last 10 YearsBuy Recommendations90.58% 452 Buy RatingsCompanies Covered73 Unique Companies Ratings Distribution499RatingsDistribution of strong buy, buy, hold, and sell ratings by Yi Chen.RatingPercentageCount Strong Buy0.4%1 ratings Buy90.2%450 ratings Hold9.4%47 ratings Sell0.0%0 ratingsOut of 499 total stock ratings issued by Yi Chen at HC Wainwright, the majority (90.2%) have been Buy recommendations, followed by 9.4% Hold and 0.4% Strong Buy.Best & Worst CallsBest Call000000.0%CODXJun 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%KALAMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ86.3% of companies on NASDAQ63 companiesOTCMKTS6.8% of companies on OTCMKTS5 companiesNYSEAMERICAN4.1% of companies on NYSEAMERICAN3 companiesNYSE2.7% of companies on NYSE2 companiesYi Chen, an analyst at HC Wainwright, currently covers 73 companies listed on NASDAQ, OTCMKTS, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare69 companies94.5%Industrials1 company1.4%Miscellaneous1 company1.4%Finance1 company1.4%Technology1 company1.4%Yi Chen of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and companies.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES22 companies30.1%BIOTECHNOLOGY21 companies28.8%PHARMACEUTICALS18 companies24.7%HEALTHCARE PROVIDERS & SERVICES5 companies6.8%LIFE SCIENCES TOOLS & SERVICES2 companies2.7%HEALTHCARE TECHNOLOGY1 company1.4%AEROSPACE & DEFENSE1 company1.4%Miscellaneous1 company1.4%FINANCIAL SERVICES1 company1.4%SOFTWARE1 company1.4% About Yi ChenDr. Chen is a Managing Director of Equity Research at H.C. Wainwright with expertise in both the biotechnology and the pharmaceutical sectors. Dr. Chen’s research covers investment opportunities in the U.S. healthcare industry. Prior to joining H.C. Wainwright, Dr. Chen worked as an Associate Director of Equity Research at Aegis Capital Corp. and as a Research Associate at Morgan Joseph TriArtisan, LLC. Dr. Chen also worked as a Trading Associate at Zhang Capital Management, a New York-based buy-side fund. Prior to that, Dr. Chen was a Research Associate at the City University of New York where his research focused primarily on protein signaling domains utilizing an RNA interference approach. Dr. Chen published several articles in leading peer-reviewed journals, presented research at various scientific conferences, and taught biology courses at Hunter College in New York City. Dr. Chen’s educational background includes a Ph.D. in biochemistry from the City University of New York and a B.S. in Biophysics from Fudan University. Dr. Chen is also a Chartered Financial Analyst (CFA) charterholder.Follow on LinkedIn Yi Chen's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEYPTEyepoint Pharmaceuticals8/18/2026Reiterated Rating$4.87Neutral$0.0000.00% ROIBLTEBelite Bio8/12/2026Boost Price Target$177.58$214.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical8/11/2026Boost Price Target$13.51$16.00Buy$0.0000.00% ROIRGNXREGENXBIO8/10/2026Lower Price Target$10.72$23.00Buy$0.0000.00% ROILFMDLifeMD8/7/2026Lower Price Target$3.40$9.00Buy$0.0000.00% ROIBDSXBiodesix8/6/2026Reiterated Rating$22.13$27.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/6/2026Lower Price Target$12.25$27.00Buy$0.0000.00% ROIOCSOculis8/5/2026Reiterated Rating$11.99$26.00Buy$0.0000.00% ROIBLCOBausch + Lomb8/3/2026Boost Price Target$16.89$21.00Buy$0.0000.00% ROITEMTempus AI8/3/2026Lower Price Target$46.69$56.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CDNACareDx7/31/2026Reiterated Rating$38.10$46.00Neutral$0.0000.00% ROIGKOSGlaukos7/30/2026Boost Price Target$170.03$195.00Buy$0.0000.00% ROIAXGNAxoGen7/30/2026Boost Price Target$41.37$53.00Buy$0.0000.00% ROISMTISanara MedTech7/30/2026Downgrade$30.29$35.00Neutral$0.0000.00% ROINPCENeuroPace7/29/2026Reiterated Rating$15.31$20.00Buy$0.0000.00% ROITEMTempus AI7/24/2026Reiterated Rating$46.01Buy$0.0000.00% ROIBLFSBioLife Solutions7/23/2026Downgrade$31.15$31.00Neutral$0.0000.00% ROIBLTEBelite Bio7/22/2026Reiterated Rating$161.08Buy$0.0000.00% ROIDRTSAlpha Tau Medical7/22/2026Reiterated Rating$13.20$15.00Buy$0.0000.00% ROIGLSIGreenwich LifeSciences7/21/2026Boost Price Target$14.47$69.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical7/16/2026Reiterated Rating$12.30$15.00Buy$0.0000.00% ROICOCHEnvoy Medical7/15/2026Reiterated Rating$0.76$2.50Buy$0.0000.00% ROIANGOAngioDynamics7/15/2026Boost Price Target$14.39$19.00Buy$0.0000.00% ROIAPYXApyx Medical7/13/2026Initiated Coverage$4.38$7.00Buy$0.0000.00% ROIOKYOOKYO Pharma7/13/2026Lower Price Target$1.69$5.00Buy$0.0000.00% ROIGKOSGlaukos7/6/2026Initiated Coverage$147.49$168.00Buy$0.0000.00% ROIGKOSGlaukos7/6/2026Initiated Coverage$148.45$168.00Buy$0.0000.00% ROIRGNXREGENXBIO7/1/2026Reiterated Rating$11.98$26.00Buy$0.0000.00% ROIRGNXREGENXBIO6/24/2026Reiterated Rating$10.19$26.00Buy$0.0000.00% ROIOCULOcular Therapeutix6/18/2026Reiterated Rating$9.54$25.00Buy$0.0000.00% ROIBDSXBiodesix6/15/2026Initiated Coverage$15.06$26.00Buy$0.0000.00% ROIBLTEBelite Bio6/15/2026Reiterated Rating$138.16$200.00Buy$0.0000.00% ROIBDSXBiodesix6/15/2026Initiated Coverage$15.60$26.00Buy$0.0000.00% ROIOCSOculis6/11/2026Reiterated Rating$10.97Buy$0.0000.00% ROIRGNXREGENXBIO6/5/2026Lower Price Target$6.13$26.00Buy$0.0000.00% ROIPMIPMI6/3/2026Reiterated Rating$0.27Neutral$0.0000.00% ROIDRTSAlpha Tau Medical6/2/2026Reiterated Rating$9.07$15.00Buy$0.0000.00% ROIOCSOculis6/1/2026Lower Price Target$22.70$26.00Buy$0.0000.00% ROILFMDLifeMD5/26/2026Reiterated Rating$4.37$10.00Buy$0.0000.00% ROIBEATHeartBeam5/22/2026Lower Price Target$0.92$2.50Buy$0.0000.00% ROIThe retirement stock I'd buy before Nvidia today (Ad)In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.Get Marc Chaikin's free presentation on this overlooked AI stock nowBLTEBelite Bio5/21/2026Reiterated Rating$143.36$200.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical5/20/2026Reiterated Rating$10.68$15.00Buy$0.0000.00% ROIPMIPMI5/18/2026Initiated Coverage$0.16Neutral$0.0000.00% ROINPCENeuroPace5/15/2026Boost Price Target$15.19$20.00Buy$0.0000.00% ROIOBIOOrchestra BioMed5/14/2026Reiterated Rating$4.06$10.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical5/12/2026Boost Price Target$10.34$15.00Buy$0.0000.00% ROIOCSOculis5/12/2026Boost Price Target$30.50$47.00Buy$0.0000.00% ROITEMTempus AI5/11/2026Lower Price Target$49.86$64.00Buy$0.0000.00% ROIAXGNAxoGen4/29/2026Boost Price Target$41.99$50.00Buy$0.0000.00% ROIBLTEBelite Bio4/22/2026Reiterated Rating$165.23$200.00Buy$0.0000.00% ROIOCSOculis4/20/2026Reiterated Rating$28.94$44.00Buy$0.0000.00% ROIVVOSVivos Therapeutics4/17/2026Lower Price Target$1.02$2.50Buy$0.0000.00% ROIBNGOBionano Genomics4/13/2026Lower Price Target$1.13$6.00Buy$0.0000.00% ROIBLTEBelite Bio4/13/2026Reiterated Rating$172.76$200.00Buy$0.0000.00% ROIOCULOcular Therapeutix4/13/2026Reiterated Rating$8.79$21.00Buy$0.0000.00% ROILPCNLipocine4/6/2026Reiterated Rating$2.05Neutral$0.0000.00% ROIVNRXVolitionRX4/2/2026Lower Price Target$3.52$20.00Buy$0.0000.00% ROICOCHEnvoy Medical3/31/2026Initiated Coverage$0.64$2.50Buy$0.0000.00% ROIVANIVivani Medical3/31/2026Lower Price Target$1.00$3.50Buy$0.0000.00% ROIHROWHarrow3/19/2026Reiterated Rating$34.48$70.00Buy$0.0000.00% ROIBEATHeartBeam3/16/2026Reiterated Rating$1.36$5.50Buy$0.0000.00% ROILFMDLifeMD3/11/2026Boost Price Target$3.91$10.00Buy$0.0000.00% ROISGPSpyglass Pharma3/10/2026Initiated Coverage$27.12$37.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical3/10/2026Reiterated Rating$6.81$12.00Buy$0.0000.00% ROIRGNXREGENXBIO3/9/2026Lower Price Target$8.65$30.00Buy$0.0000.00% ROITEMTempus AI3/9/2026Boost Price Target$50.32$95.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/5/2026Boost Price Target$18.00$30.00Buy$0.0000.00% ROIHROWHarrow3/4/2026Boost Price Target$38.60$70.00Buy$0.0000.00% ROIOCSOculis3/4/2026Boost Price Target$27.99$44.00Buy$0.0000.00% ROIBLTEBelite Bio3/3/2026Boost Price Target$180.09$200.00Buy$0.0000.00% ROIBLCOBausch + Lomb2/23/2026Boost Price Target$17.79$20.00Buy$0.0000.00% ROIRGNXREGENXBIO2/10/2026Lower Price Target$8.92$32.00Buy$0.0000.00% ROIOKYOOKYO Pharma1/29/2026Reiterated Rating$2.04$7.00Buy$0.0000.00% ROIRGNXREGENXBIO1/29/2026Reiterated Rating$11.50$34.00Buy$0.0000.00% ROIBLTEBelite Bio1/28/2026Reiterated Rating$167.34$185.00Buy$0.0000.00% ROINPCENeuroPace1/27/2026Boost Price Target$16.23$19.00Buy$0.0000.00% ROISMTISanara MedTech1/26/2026Reiterated Rating$20.98$36.00Buy$0.0000.00% ROILPCNLipocine1/21/2026Reiterated Rating$9.92$15.00Buy$0.0000.00% ROIVRAXVirax Biolabs Group1/9/2026Reiterated Rating$9.58$25.00Buy$0.0000.00% ROIGLSIGreenwich LifeSciences12/30/2025Boost Price Target$24.78$50.00Buy$0.0000.00% ROIBLFSBioLife Solutions12/29/2025Reiterated Rating$24.90$32.00Buy$0.0000.00% ROILEXXLexaria Bioscience12/26/2025Lower Price Target$8.45$22.50Buy$0.0000.00% ROIBEATHeartBeam12/11/2025Reiterated Rating$2.01Speculative Buy$0.0000.00% ROIBEATHeartBeam12/11/2025Set Price Target$2.23$5.50$0.0000.00% ROIBEATHeartBeam12/10/2025Set Price Target$1.54$5.50$0.0000.00% ROIDRTSAlpha Tau Medical12/10/2025Reiterated Rating$4.71Buy$0.0000.00% ROIOCULOcular Therapeutix12/8/2025Boost Price Target$12.58$21.00Buy$0.0000.00% ROIBEATHeartBeam12/8/2025Initiated Coverage$0.72$2.50Buy$0.0000.00% ROIBEATHeartBeam12/8/2025Initiated Coverage$0.79$2.50Buy$0.0000.00% ROIAXGNAxoGen12/5/2025Boost Price Target$33.58$39.00Buy$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techBLTEBelite Bio12/1/2025Boost Price Target$150.72$185.00Buy$0.0000.00% ROIOCULOcular Therapeutix11/25/2025Reiterated Rating$12.10$19.00Buy$0.0000.00% ROIBLFSBioLife Solutions11/24/2025Reiterated Rating$26.53$32.00Buy$0.0000.00% ROIBNGOBionano Genomics11/24/2025Reiterated Rating$1.62$7.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical11/24/2025Reiterated Rating$3.82$9.00Buy$0.0000.00% ROICODXCo-Diagnostics11/24/2025Reiterated Rating$0.35Neutral$0.0000.00% ROILFMDLifeMD11/19/2025Lower Price Target$3.98$9.00Buy$0.0000.00% ROIVVOSVivos Therapeutics11/17/2025Initiated Coverage$2.34$7.00Buy$0.0000.00% ROIBRNSBarinthus Biotherapeutics11/17/2025Boost Price Target$0.80$4.00Buy$0.0000.00% ROIVNRXVolitionRX11/17/2025Lower Price Target$6.30$30.00Buy$0.0000.00% ROISMTISanara MedTech11/14/2025Lower Price Target$19.61$36.00Buy$0.0000.00% ROILPCNLipocine11/13/2025Lower Price Target$2.92$7.00Buy$0.0000.00% ROIHROWHarrow11/12/2025Boost Price Target$38.74$69.00Buy$0.0000.00% ROIOCSOculis11/11/2025Boost Price Target$19.42$42.00Buy$0.0000.00% ROITEMTempus AI11/7/2025Lower Price Target$72.09$89.00Buy$0.0000.00% ROIEDSAEdesa Biotech11/3/2025Reiterated Rating$1.77$5.00Buy$0.0000.00% ROIBLCOBausch + Lomb10/31/2025Boost Price Target$15.20$17.00Buy$0.0000.00% ROIAXGNAxoGen10/30/2025Boost Price Target$22.62$26.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical10/22/2025Reiterated Rating$4.18$9.00Buy$0.0000.00% ROIOCULOcular Therapeutix10/8/2025Boost Price Target$11.52$19.00Buy$0.0000.00% ROIOCSOculis10/7/2025Boost Price Target$18.56$36.00Buy$0.0000.00% ROIICCMIceCure Medical10/7/2025Boost Price Target$30.00$75.00Buy$0.0000.00% ROIRGNXREGENXBIO10/7/2025Reiterated Rating$10.69$34.00Buy$0.0000.00% ROIAXGNAxoGen9/30/2025Initiated Coverage$17.26$25.00Buy$0.0000.00% ROIVNRXVolitionRX9/30/2025Reiterated Rating$12.46$50.00Buy$0.0000.00% ROIAXGNAxoGen9/30/2025Initiated Coverage$17.84$25.00Buy$0.0000.00% ROIHROWHarrow9/29/2025Reiterated Rating$47.10$64.00Buy$0.0000.00% ROIKALAKALA BIO9/29/2025Reiterated Rating$2.13Neutral$0.0000.00% ROIOKYOOKYO Pharma9/23/2025Reiterated Rating$2.25$7.00Buy$0.0000.00% ROIKALAKALA BIO9/17/2025Boost Price Target$916.00$1,750.00Buy$0.0000.00% ROIBLTEBelite Bio9/15/2025Lower Price Target$69.48$98.00Buy$0.0000.00% ROITEMTempus AI9/12/2025Boost Price Target$88.78$98.00Buy$0.0000.00% ROIANIXAnixa Biosciences9/11/2025Reiterated Rating$3.02$7.00Buy$0.0000.00% ROITRMLTourmaline Bio9/10/2025Downgrade$47.64$48.00Neutral$0.0000.00% ROIRGNXREGENXBIO9/8/2025Reiterated Rating$9.71$34.00Buy$0.0000.00% ROIOBIOOrchestra BioMed9/4/2025Lower Price Target$2.72$10.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical9/3/2025Reiterated Rating$3.48$9.00Buy$0.0000.00% ROIKPRXKiora Pharmaceuticals9/2/2025Reiterated Rating$2.78$10.00Buy$0.0000.00% ROITEMTempus AI9/2/2025Initiated Coverage$75.86$90.00Buy$0.0000.00% ROIVANIVivani Medical9/2/2025Reiterated Rating$1.15$4.00Buy$0.0000.00% ROIELDNEledon Pharmaceuticals9/2/2025Reiterated Rating$2.59$9.00Buy$0.0000.00% ROIOCSOculis8/22/2025Boost Price Target$17.80$33.00Buy$0.0000.00% ROILPCNLipocine8/20/2025Reiterated Rating$2.96$8.00Buy$0.0000.00% ROIRGNXREGENXBIO8/19/2025Reiterated Rating$8.71$34.00Buy$00.0000.00% ROISMTISanara MedTech8/18/2025Boost Price Target$29.68$54.00Buy$00.0000.00% ROIBNGOBionano Genomics8/18/2025Reiterated Rating$3.04$11.00Buy$0.0000.00% ROISMTISanara MedTech8/18/2025Boost Price Target$29.68$54.00Buy$00.0000.00% ROIICCMIceCure Medical8/15/2025Lower Price Target$25.25$60.00Buy$0.0000.00% ROIHROWHarrow8/13/2025Boost Price Target$34.83$64.00Buy$00.0000.00% ROISRTSSensus Healthcare8/12/2025Lower Price Target$3.18$8.00Buy$0.0000.00% ROIThe retirement stock I'd buy before Nvidia today (Ad)In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.Get Marc Chaikin's free presentation on this overlooked AI stock nowBLFSBioLife Solutions8/8/2025Reiterated Rating$20.64$32.00Buy$00.0000.00% ROILFMDLifeMD8/7/2025Lower Price Target$6.53$13.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals8/6/2025Boost Price Target$10.52$23.00Buy$00.0000.00% ROIZYXIZynex8/1/2025Downgrade$2.23Neutral$0.0000.00% ROIBLCOBausch + Lomb7/31/2025Boost Price Target$13.60$16.00Buy$00.0000.00% ROILEXXLexaria Bioscience7/29/2025Lower Price Target$13.43$60.00Buy$0.0000.00% ROICLSDClearside Biomedical7/18/2025Downgrade$9.03$75.00Neutral$0.0000.00% ROIANGOAngioDynamics7/16/2025Reiterated Rating$8.49$16.00Buy$00.0000.00% ROIBLTEBelite Bio7/3/2025Reiterated Rating$56.81$100.00Buy$000.0000.00% ROILEXXLexaria Bioscience7/1/2025Lower Price Target$13.05$75.00Buy$0.0000.00% ROIZYXIZynex6/30/2025Reiterated Rating$2.62$8.00Buy$0.0000.00% ROIEDSAEdesa Biotech6/27/2025Upgrade$2.02$5.00Strong-Buy$0.0000.00% ROIELDNEledon Pharmaceuticals6/18/2025Upgrade$2.81$9.00Buy$0.0000.00% ROILPCNLipocine5/29/2025Upgrade$3.39$8.00Strong-Buy$0.0000.00% ROIOCULOcular Therapeutix5/29/2025Reiterated Rating$8.03$15.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals5/29/2025Reiterated Rating$7.05$22.00Buy$00.0000.00% ROIICCMIceCure Medical5/29/2025Reiterated Rating$31.20$75.00Buy$0.0000.00% ROINPCENeuroPace5/28/2025Initiated Coverage$12.66$18.00Buy$00.0000.00% ROIKALAKALA BIO5/23/2025Lower Price Target$204.50$600.00Buy$0.0000.00% ROICLSDClearside Biomedical5/23/2025Lower Price Target$12.80$75.00Buy$0.0000.00% ROIVANIVivani Medical5/19/2025Reiterated Rating$1.03$4.00Buy$0.0000.00% ROIBLTEBelite Bio5/15/2025Reiterated Rating$61.60$100.00Buy$000.0000.00% ROIBLFSBioLife Solutions5/13/2025Reiterated Rating$23.89$30.00Buy$00.0000.00% ROICDNACareDx5/5/2025Reiterated Rating$15.00$25.00Neutral$00.0000.00% ROIOKYOOKYO Pharma5/5/2025Reiterated Rating$1.36$7.00Buy$0.0000.00% ROITRMLTourmaline Bio5/5/2025Reiterated Rating$16.30$50.00Buy$0.0000.00% ROIBLCOBausch + Lomb5/2/2025Lower Price Target$11.59$15.00Buy$00.0000.00% ROIZYXIZynex4/30/2025Lower Price Target$2.23$8.00Buy$0.0000.00% ROILFMDLifeMD4/30/2025Reiterated Rating$8.62$14.00Buy$0.0000.00% ROIDRTSAlpha Tau Medical4/29/2025Reiterated Rating$2.68$9.00Buy$0.0000.00% ROIGLSIGreenwich LifeSciences4/21/2025Boost Price Target$8.95$39.00Buy$00.0000.00% ROIOCSOculis4/17/2025Boost Price Target$18.02$32.00Buy$00.0000.00% ROIBNGOBionano Genomics4/9/2025Initiated Coverage$2.83$10.00Buy$0.0000.00% ROIVNRXVolitionRX4/8/2025Initiated Coverage$10.00$50.00Buy$0.0000.00% ROIANGOAngioDynamics4/7/2025Reiterated Rating$9.11$16.00Buy$0.0000.00% ROIOPKOPKO Health4/7/2025Reiterated Rating$1.53$3.00Buy$0.0000.00% ROIOBIOOrchestra BioMed4/4/2025Lower Price Target$3.11$12.00Buy$0.0000.00% ROIKALAKALA BIO4/4/2025Reiterated Rating$231.50$750.00Buy$0.0000.00% ROISRTSSensus Healthcare4/4/2025Reiterated Rating$4.51$12.00Buy$0.0000.00% ROICLSDClearside Biomedical3/31/2025Reiterated Rating$14.25$90.00Buy$0.0000.00% ROIVRAXVirax Biolabs Group3/31/2025Initiated Coverage$29.00$75.00Buy$0.0000.00% ROIICCMIceCure Medical3/28/2025Reiterated Rating$33.15$75.00Buy$00.0000.00% ROIKPRXKiora Pharmaceuticals3/28/2025Reiterated Rating$3.02$10.00Buy$0.0000.00% ROICODXCo-Diagnostics3/28/2025Lower Price Target$9.72$30.00Neutral$0.0000.00% ROIANIXAnixa Biosciences3/25/2025Reiterated Rating$3.20$7.00Buy$0.0000.00% ROIBRNSBarinthus Biotherapeutics3/21/2025Reiterated Rating$1.01$3.00Buy$0.0000.00% ROIOPKOPKO Health3/19/2025Reiterated Rating$1.79$3.00Buy$0.0000.00% ROIBLTEBelite Bio3/18/2025Reiterated Rating$67.81$100.00Buy$000.0000.00% ROIDRTSAlpha Tau Medical3/17/2025Reiterated Rating$2.65$9.00Buy$0.0000.00% ROITRMLTourmaline Bio3/14/2025Boost Price Target$17.04$50.00Buy$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techOCSOculis3/13/2025Lower Price Target$18.84$29.00Buy$00.0000.00% ROILFMDLifeMD3/12/2025Boost Price Target$5.57$14.00Buy$0.0000.00% ROIZYXIZynex3/12/2025Lower Price Target$7.00$15.00Buy$0.0000.00% ROIOPKOPKO Health3/12/2025Reiterated Rating$1.77$3.00Buy$0.0000.00% ROIOBIOOrchestra BioMed3/10/2025Reiterated Rating$4.23$14.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals3/6/2025Reiterated Rating$6.58$22.00Buy$00.0000.00% ROICLSDClearside Biomedical3/6/2025Reiterated Rating$14.40$90.00Buy$0.0000.00% ROIOCULOcular Therapeutix3/4/2025Reiterated Rating$5.93$15.00Buy$00.0000.00% ROIOPKOPKO Health3/3/2025Reiterated Rating$1.74$3.00Buy$0.0000.00% ROICDNACareDx3/3/2025Lower Price Target$22.15$25.00Neutral$00.0000.00% ROIOKYOOKYO Pharma2/18/2025Reiterated Rating$1.10$7.00Buy$0.0000.00% ROIBLCOBausch + Lomb2/18/2025Reiterated Rating$16.44$23.00Buy$00.0000.00% ROIANIXAnixa Biosciences2/18/2025Reiterated Rating$3.06$7.00Buy$0.0000.00% ROIKALAKALA BIO2/13/2025Reiterated Rating$372.00$750.00Buy$00.0000.00% ROIGLSIGreenwich LifeSciences2/11/2025Reiterated Rating$12.25$38.00Buy$00.0000.00% ROISRTSSensus Healthcare2/10/2025Boost Price Target$5.84$12.00Buy$0.0000.00% ROIOKYOOKYO Pharma2/10/2025Reiterated Rating$1.14$7.00Buy$0.0000.00% ROIHROWHarrow2/6/2025Initiated Coverage$30.89$57.00Buy$00.0000.00% ROILEXXLexaria Bioscience1/24/2025Lower Price Target$27.30$105.00Buy$00.0000.00% ROIRGNXREGENXBIO1/15/2025Reiterated Rating$7.05$36.00Buy$00.0000.00% ROICDNACareDx1/14/2025Reiterated Rating$25.07$26.00Neutral$00.0000.00% ROIBRNSBarinthus Biotherapeutics1/13/2025Lower Price Target$1.03$3.00Buy$0.0000.00% ROIANGOAngioDynamics1/10/2025Boost Price Target$12.94$15.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupBarclaysMorgan StanleyBerenberg BankGuggenheimB. Riley FinancialShore Capital GroupCICC ResearchUBS GroupRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD Cowen Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
